Alzheimer’s Drug Lecanemab Works by “Switching On” the Brain’s Cleanup Cells
April 7, 2026
Study reveals Fc fragment of antibody is essential for activating microglia to clear amyloid plaques
2 min read
False
Advertisement
Development & Clinical
Human-Relevant Models Come of Age
April 6, 2026
Why vascularized tissues are gaining traction
7 min read
CAR Tregs Move Into Neurodegeneration
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
Could Mass Spec Overcome the CAR T Solid Tumor Barrier?
April 1, 2026
Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.
6 min read
Turning Baby Teeth Into Cell Therapy
March 26, 2026
SHED cells show early promise as a potential regenerative therapy in cerebral palsy research
2 min read
CAR-Engineered Astrocytes in Alzheimer’s Models
March 25, 2026
Preclinical findings show engineered astrocytes reduce amyloid buildup in mouse models and demonstrate a potential therapeutic approach
1 min read
Japan Clears First iPSC Therapies for Clinical Use
March 25, 2026
Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials
2 min read
The Lipitor Warning for GLP-1 Drugmakers
By Joe Renny
March 23, 2026
Pfizer’s Lipitor experience shows the structural risks that today’s GLP-1 innovators may soon face
7 min read
saRNA Injection Targets Cardiac Injury
March 17, 2026
Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction
1 min read
Armoring CAR-T Against Solid Tumors
March 17, 2026
UCLA researchers create armored CAR-T cells that show promise for treating solid tumors
2 min read
